Application of animal models in cancer research: recent progress and future prospects

Z Li, W Zheng, H Wang, Y Cheng, Y Fang… - Cancer management …, 2021 - Taylor & Francis
Animal models refers to the animal experimental objects and related materials that can
simulate human body established in medical research. As the second-largest disease in …

[HTML][HTML] Zebrafish as a model for inflammation and drug discovery

R Zanandrea, CD Bonan, MM Campos - Drug Discovery Today, 2020 - Elsevier
Highlights•Zebrafish are a useful tool for screening new drugs for inflammation.•This teleost
shares several inflammatory mediators and receptors with mammals.•The real-time …

RGD-engineered nanoparticles as an innovative drug delivery system in cancer therapy

M Sanati, AR Afshari, S Aminyavari… - Journal of Drug Delivery …, 2023 - Elsevier
The poor efficiency and drastic adverse effects of current cancer therapies entail a radical
shift in treatment paradigms, which require developing cutting-edge therapeutics in …

Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities

AR Poh, M Ernst - Oncogene, 2023 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignant disease with a 5-
year survival rate of< 10%. Aberrant activation or elevated expression of the tyrosine kinase …

Cell adhesion molecules in fibrotic diseases

Q Hu, K Saleem, J Pandey, AN Charania, Y Zhou, C He - Biomedicines, 2023 - mdpi.com
Mechanisms underlying the pathogenesis of tissue fibrosis remain incompletely understood.
Emerging evidence suggests that cell adhesion molecules (CAMs) are critical in fibrotic …

Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy

A Parkin, J Man, P Timpson, M Pajic - The FEBS journal, 2019 - Wiley Online Library
Pancreatic cancer, a disease with extremely poor prognosis, has been notoriously resistant
to virtually all forms of treatment. The dynamic crosstalk that occurs between tumour cells …

RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions

H Javid, MA Oryani, N Rezagholinejad… - Cancer …, 2024 - Wiley Online Library
RGD peptide can be found in cell adhesion and signaling proteins, such as fibronectin,
vitronectin, and fibrinogen. RGD peptides' principal function is to facilitate cell adhesion by …

Activated hepatic stellate cells (HSCs) exert immunosuppressive effects in hepatocellular carcinoma by producing complement C3

Y Xu, Y Huang, W Xu, X Zheng, X Yi… - OncoTargets and …, 2020 - Taylor & Francis
Objective Hepatic stellate cells (HSCs) are the important players in liver cirrhosis and liver
cancer. They also act as critical mediators of immunosuppression in hepatocellular …

Liver tumor-initiating cells initiate the formation of a stiff cancer stem cell microenvironment niche by secreting LOX

W Zhao, M Lv, X Yang, J Zhou, B Xing… - …, 2022 - academic.oup.com
Accumulating evidence has shown that the traits of tumor-initiating cells (TICs) are controlled
by the microenvironment niches (MENs), but the composition and remodeling mechanisms …

RETRACTED ARTICLE: Hepatic stellate cell mediates transcription of TNFSF14 in hepatocellular carcinoma cells via H2S/CSE-JNK/JunB signaling pathway

Y Ma, S Wang, Y Wu, B Liu, L Li, W Wang… - Cell death & …, 2022 - nature.com
Hepatic stellate cells (HSC) and hydrogen sulfide (H2S) both play important roles in the
development of hepatocellar carcinoma (HCC). Whereas, in the microenvironment of HCC …